Welcome and Opening Remarks

Richard J. Derman, MD, MPH, FACOG Richard J. Derman was appointed the first Associate Provost of the Office of Global Affairs, Director of Global Health Research, and Professor of Obstetrics and Gynecology at Thomas Jefferson University in May 2016. He has joined the Jefferson family to help build a sustainable academic model for our Global Jefferson enterprise. Dr. Derman’s career has focused on research and clinical care, addressing underserved women, both in the US and in under-resourced countries. He has risen to high levels of operating responsibility at both global health agencies and as an endowed chair and associate dean within US academic institutions. Dr. Derman has served as a consultant to NGOs and to the World Health Organization. The results of his collaborative maternal child health research with partners in Belgaum, has been formally recognized by DHHS, NIH, USAID and the government of India. Before completing his residency in obstetrics and gynecology at Cornell University, the New York Lying-In Hospital, and his master’s in public health degree from Johns Hopkins University, Dr. Derman served as a Peace Corps physician in India and a medical director of the Peace Corps in Washington, D.C. Dr. Derman served as medical director and Principal Investigator at the Center of Excellence in Women’s Health at University of Illinois and University of Missouri, Kansas City, as well as Christiana Care Health Systems. He was the inaugural Marie E. Pinizzotto, MD, Endowed Chair of Obstetrics and Gynecology at Christiana Care Health System. Dr. Derman is a principal investigator of the Global Research Network for Women’s and Children’s Health, funded by the National Institutes of Health, and is involved in research funded by the World Health Organization and the Gates Foundation. He has published more than 100 articles in indexed, peer-reviewed journals and is a leading advocate for outcomes research in women’s health, currently serving as founding President of the Society for Health Outcomes in Women. Mark L. Tykocinski, MD Mark L. Tykocinski serves as Provost and Executive Vice President for Academic Affairs, Thomas Jefferson University, and the Anthony F. and Gertrude M. DePalma Dean of Sidney Kimmel Medical College at Thomas Jefferson University. For over five years, he also served as President of Jefferson University Physicians. Before joining Jefferson in 2008, he was Professor and Chair of the Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine for a decade. Dr. Tykocinski’s research contributions have been in the fields of molecular and cellular immunology, for which he holds a series of research patents. He serves as SAB Chair for KAHR-Medical, the Israeli biotech company he founded in 2007 for fusion protein pharmaceuticals. He is Past President of the American Society for Investigative Pathology/Federation of American Societies for Experimental Biology and the Association of Pathology Chairs. He has been on the editorial boards of the American Journal of Pathology, Molecular Oncology and Genetics Research, and was honored with the Warner-Lambert/Parke-Davis Award for Outstanding Research from ASIP/FASEB. He earned a B.A. in biology magna cum laude from Yale University and his M.D. from New York University